Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

CTSO Stock Forecast, Price Targets, Chart, Dividends & Analysis

CytoSorbents Corporation logo

CytoSorbents Corporation

Sector: Healthcare   

Industry: Diagnostics & Research

0.89
 
USD
  
0.01
  
(1.17%)
Previous close: 0.8807  Open: 0.861  Bid: 0.82  Ask: 0.92
52 week range    
0.70   
   2.15
Mkt Cap: 48 M  Avg Vol (90 Days): 127,688
Peers   
VIVO / 
HOLX / 
NEPH / 
BSX / 
DXR / 
Last updated: Friday 13th December 2024

Stock Rankings

51
MarketXLS Rank
60
Value
46
Technical
47
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BSX

133 B73.3290.42

DXR

0 B8.4

HOLX

17 B22.7675.09

NEPH

0 B-121.55

VASO

VIVO

33.97
Financials

CTSO Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends9 M335731.0
AcquiredInProcessRnDIncome2 M20 M
Amortization of intangibles85600.0109600.0189000.0200000.0212000.0
Basic EPS from continuing operations-0.6-0.2-0.57-0.75-0.64
Basic EPS total-0.08-0.6-0.2-0.57-0.75-0.64
Basic weighted shares outstanding14 M25 M25 M28 M31 M32 M39 M43 M44 M45 M
Cost of sales-2 M-2 M-4 M-6 M-7 M7 M11 M11 M14 M14 M
Depreciation-48429.0-87397.0-126112.0-177776.0-329469.0495728.0553946.0571156.0688565.01 M
DepreciationAndAmortization-48429.0-87397.0-126112.0-177776.0-329469.0495728.0553946.0571156.0688565.01 M
Diluted EPS total-1.29-0.33-0.46-0.32-0.56-0.6-0.2-0.57-0.75-0.64
Diluted normalized net income/share-0.57-0.75-0.64
Diluted weighted shares outstanding7 M25 M26 M26 M31 M32 M39 M43 M44 M45 M
GeneralAndAdministrativeExpense896847.01 M1 M1 M2 M24 M32 M38 M37 M38 M
Gross operating profit2 M3 M6 M10 M15 M18 M28 M29 M15 M17 M
Income before tax-10 M-8 M-12 M-9 M-18 M-20 M-9 M-25 M-34 M-29 M
Income taxes-385642.0-324606.0-318550.0-676739.0-619546.0-1 M-1 M-736003.0-1 M-813739.0
Interest income-310024.09301.0-231804.0-749076.0-1 M-1 M-1 M28007.0132597.0-157891.0
InterestExpenseNonOperating-199000.01 M
InterestIncomeOperating13 M
MiscOtherSpecialCharges-2 M1 M-175418.013 M23 M-67303.096754.0
Net income from total operations-9 M-8 M-12 M-8 M-17 M-19 M-8 M-25 M-33 M-29 M
NetIncomeCommonStockholders-19 M-8 M-12 M-9 M-17 M-19 M-8 M-25 M-33 M-29 M
NetIncomeContinuousOperations-9 M-8 M-12 M-8 M-17 M-19 M-8 M-25 M-33 M-29 M
NetNonOperatingInterestIncomeExpense-310024.09301.0-231804.0-749076.0-1 M-1 M-1 M28007.0132597.0-157891.0
NonRecurringOperationExpense-280000.0
Normalized income-30 M
Operating income-7 M-9 M-11 M-25 M-38 M-19 M-10 M-23 M-32 M-31 M
Operating income before depreciation (EBITDA)-10 M-8 M-12 M-9 M-17 M-20 M-10 M-22 M-30 M-29 M
OperatingExpense-9 M-12 M-17 M-19 M-31 M37 M40 M55 M47 M48 M
Other income net2 M-1 M175418.0-2 M-23 M-3 M2 M
Other special charges-637000.0
OtherGandA896847.01 M1 M1 M2 M24 M32 M38 M37 M38 M
OtherOperatingExpenses-270901.0
OtherunderPreferredStockDividend9 M335731.0
PreferredStockDividends9 M335731.0
PromotionAndAdvertising-142000.0-282000.0-173000.0-162000.0-212000.0314000.0285000.0615000.0582000.0253000.0
RealizedCapitalGain2 M
RentAndLandingFees-328000.0-411000.0-473000.0-676000.0-805000.0
Research & development expense2 M4 M5 M3 M8 M12 M9 M16 M15 M16 M
ResearchExpense2 M4 M5 M3 M8 M12 M9 M16 M15 M16 M
Revenue per share-17118.0-25573.0-35501.0-40495.0-61082.085804.0106842.0160422.0194056.0434836.0
SalariesAndWages-696000.0-382000.0-3 M-3 M-4 M315000.0914000.01 M260000.0
Selling Gen & administrative expense6 M8 M12 M16 M23 M24 M32 M38 M37 M38 M
SellingAndMarketingExpense6 M7 M11 M15 M21 M314000.0285000.0615000.0582000.0253000.0
SellingExpense6 M7 M11 M15 M21 M
Special income/charges637000.0280000.0
Total Income available for interest expense (EBIT)-10 M-8 M-12 M-9 M-18 M-20 M-10 M-23 M-32 M-31 M
Total common shares outstanding25 M25 M26 M29 M32 M35 M43 M44 M44 M54 M
Total net income-9 M-8 M-12 M-8 M-17 M-19 M-8 M-25 M-33 M-29 M
Total ordinary shares55 M55 M55 M55 M55 M55 M55 M55 M55 M55 M
Total revenues4 M5 M10 M15 M23 M25 M41 M43 M35 M36 M
TotalExpenses-11 M-14 M-21 M-25 M-38 M44 M51 M66 M61 M62 M
TotalRevenue3 M4 M8 M15 M23 M25 M41 M43 M29 M31 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University